Uremic Pericarditis

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 75 Experts worldwide ranked by ideXlab platform

Allan L Klein - One of the best experts on this subject based on the ideXlab platform.

  • clinical outcomes of pericardial effusions in end stage renal disease Pericarditis associated versus asymptomatic
    Journal of the American College of Cardiology, 2018
    Co-Authors: Karim Abdur Rehman, Jorge Betancor, Bo Xu, Arnav Kumar, Carlos Godoy Rivas, Leslie P Wong, Craig R Asher, Paul Cremer, Allan L Klein
    Abstract:

    Clinical outcomes associated with pericardial effusions related to Uremic Pericarditis (UP) have not been clearly differentiated from asymptomatic effusions in patients with ESRD. Our objectives are: 1) to assess whether pericardial effusions associated with UP are more likely to result in

  • Uremic Pericarditis pericardial effusion and constrictive Pericarditis in end stage renal disease insights and pathophysiology
    Clinical Cardiology, 2017
    Co-Authors: Karim Abdur Rehman, Jorge Betancor, Bo Xu, Arnav Kumar, Carlos Godoy Rivas, Kimi Sato, Leslie P Wong, Craig R Asher, Allan L Klein
    Abstract:

    A rising prevalence of end-stage renal disease (ESRD) has led to a rise in ESRD-related pericardial syndromes, calling for a better understanding of its pathophysiology, diagnoses, and management. Uremic Pericarditis, the most common manifestation of Uremic pericardial disease, is a contemporary problem that calls for intensive hemodialysis, anti-inflammatories, and often, drainage of large inflammatory pericardial effusions. Likewise, asymptomatic pericardial effusions can become large and impact the hemodynamics of patients on chronic hemodialysis. Constrictive Pericarditis is also well documented in this population, ultimately resulting in pericardiectomy for definitive treatment. The management of pericardial diseases in ESRD patients involves internists, cardiologists, and nephrologists. Current guidelines lack clarity with respect to the management of pericardial processes in the ESRD population. Our review aims to describe the etiology, classification, clinical manifestations, diagnostic imaging tools, and treatment options of pericardial diseases in this population.

  • Uremic Pericarditis pericardial effusion and constrictive Pericarditis in end stage renal disease insights and pathophysiology
    Clinical Cardiology, 2017
    Co-Authors: Karim Abdur Rehman, Jorge Betancor, Arnav Kumar, Carlos Godoy Rivas, Kimi Sato, Leslie P Wong, Craig R Asher, Allan L Klein
    Abstract:

    A rising prevalence of end-stage renal disease (ESRD) has led to a rise in ESRD-related pericardial syndromes, calling for a better understanding of its pathophysiology, diagnoses, and management. Uremic Pericarditis, the most common manifestation of Uremic pericardial disease, is a contemporary problem that calls for intensive hemodialysis, anti-inflammatories, and often, drainage of large inflammatory pericardial effusions. Likewise, asymptomatic pericardial effusions can become large and impact the hemodynamics of patients on chronic hemodialysis. Constrictive Pericarditis is also well documented in this population, ultimately resulting in pericardiectomy for definitive treatment. The management of pericardial diseases in ESRD patients involves internists, cardiologists, and nephrologists. Current guidelines lack clarity with respect to the management of pericardial processes in the ESRD population. Our review aims to describe the etiology, classification, clinical manifestations, diagnostic imaging tools, and treatment options of pericardial diseases in this population.

Karim Abdur Rehman - One of the best experts on this subject based on the ideXlab platform.

  • clinical outcomes of pericardial effusions in end stage renal disease Pericarditis associated versus asymptomatic
    Journal of the American College of Cardiology, 2018
    Co-Authors: Karim Abdur Rehman, Jorge Betancor, Bo Xu, Arnav Kumar, Carlos Godoy Rivas, Leslie P Wong, Craig R Asher, Paul Cremer, Allan L Klein
    Abstract:

    Clinical outcomes associated with pericardial effusions related to Uremic Pericarditis (UP) have not been clearly differentiated from asymptomatic effusions in patients with ESRD. Our objectives are: 1) to assess whether pericardial effusions associated with UP are more likely to result in

  • Uremic Pericarditis pericardial effusion and constrictive Pericarditis in end stage renal disease insights and pathophysiology
    Clinical Cardiology, 2017
    Co-Authors: Karim Abdur Rehman, Jorge Betancor, Bo Xu, Arnav Kumar, Carlos Godoy Rivas, Kimi Sato, Leslie P Wong, Craig R Asher, Allan L Klein
    Abstract:

    A rising prevalence of end-stage renal disease (ESRD) has led to a rise in ESRD-related pericardial syndromes, calling for a better understanding of its pathophysiology, diagnoses, and management. Uremic Pericarditis, the most common manifestation of Uremic pericardial disease, is a contemporary problem that calls for intensive hemodialysis, anti-inflammatories, and often, drainage of large inflammatory pericardial effusions. Likewise, asymptomatic pericardial effusions can become large and impact the hemodynamics of patients on chronic hemodialysis. Constrictive Pericarditis is also well documented in this population, ultimately resulting in pericardiectomy for definitive treatment. The management of pericardial diseases in ESRD patients involves internists, cardiologists, and nephrologists. Current guidelines lack clarity with respect to the management of pericardial processes in the ESRD population. Our review aims to describe the etiology, classification, clinical manifestations, diagnostic imaging tools, and treatment options of pericardial diseases in this population.

  • Uremic Pericarditis pericardial effusion and constrictive Pericarditis in end stage renal disease insights and pathophysiology
    Clinical Cardiology, 2017
    Co-Authors: Karim Abdur Rehman, Jorge Betancor, Arnav Kumar, Carlos Godoy Rivas, Kimi Sato, Leslie P Wong, Craig R Asher, Allan L Klein
    Abstract:

    A rising prevalence of end-stage renal disease (ESRD) has led to a rise in ESRD-related pericardial syndromes, calling for a better understanding of its pathophysiology, diagnoses, and management. Uremic Pericarditis, the most common manifestation of Uremic pericardial disease, is a contemporary problem that calls for intensive hemodialysis, anti-inflammatories, and often, drainage of large inflammatory pericardial effusions. Likewise, asymptomatic pericardial effusions can become large and impact the hemodynamics of patients on chronic hemodialysis. Constrictive Pericarditis is also well documented in this population, ultimately resulting in pericardiectomy for definitive treatment. The management of pericardial diseases in ESRD patients involves internists, cardiologists, and nephrologists. Current guidelines lack clarity with respect to the management of pericardial processes in the ESRD population. Our review aims to describe the etiology, classification, clinical manifestations, diagnostic imaging tools, and treatment options of pericardial diseases in this population.

Craig R Asher - One of the best experts on this subject based on the ideXlab platform.

  • clinical outcomes of pericardial effusions in end stage renal disease Pericarditis associated versus asymptomatic
    Journal of the American College of Cardiology, 2018
    Co-Authors: Karim Abdur Rehman, Jorge Betancor, Bo Xu, Arnav Kumar, Carlos Godoy Rivas, Leslie P Wong, Craig R Asher, Paul Cremer, Allan L Klein
    Abstract:

    Clinical outcomes associated with pericardial effusions related to Uremic Pericarditis (UP) have not been clearly differentiated from asymptomatic effusions in patients with ESRD. Our objectives are: 1) to assess whether pericardial effusions associated with UP are more likely to result in

  • Uremic Pericarditis pericardial effusion and constrictive Pericarditis in end stage renal disease insights and pathophysiology
    Clinical Cardiology, 2017
    Co-Authors: Karim Abdur Rehman, Jorge Betancor, Bo Xu, Arnav Kumar, Carlos Godoy Rivas, Kimi Sato, Leslie P Wong, Craig R Asher, Allan L Klein
    Abstract:

    A rising prevalence of end-stage renal disease (ESRD) has led to a rise in ESRD-related pericardial syndromes, calling for a better understanding of its pathophysiology, diagnoses, and management. Uremic Pericarditis, the most common manifestation of Uremic pericardial disease, is a contemporary problem that calls for intensive hemodialysis, anti-inflammatories, and often, drainage of large inflammatory pericardial effusions. Likewise, asymptomatic pericardial effusions can become large and impact the hemodynamics of patients on chronic hemodialysis. Constrictive Pericarditis is also well documented in this population, ultimately resulting in pericardiectomy for definitive treatment. The management of pericardial diseases in ESRD patients involves internists, cardiologists, and nephrologists. Current guidelines lack clarity with respect to the management of pericardial processes in the ESRD population. Our review aims to describe the etiology, classification, clinical manifestations, diagnostic imaging tools, and treatment options of pericardial diseases in this population.

  • Uremic Pericarditis pericardial effusion and constrictive Pericarditis in end stage renal disease insights and pathophysiology
    Clinical Cardiology, 2017
    Co-Authors: Karim Abdur Rehman, Jorge Betancor, Arnav Kumar, Carlos Godoy Rivas, Kimi Sato, Leslie P Wong, Craig R Asher, Allan L Klein
    Abstract:

    A rising prevalence of end-stage renal disease (ESRD) has led to a rise in ESRD-related pericardial syndromes, calling for a better understanding of its pathophysiology, diagnoses, and management. Uremic Pericarditis, the most common manifestation of Uremic pericardial disease, is a contemporary problem that calls for intensive hemodialysis, anti-inflammatories, and often, drainage of large inflammatory pericardial effusions. Likewise, asymptomatic pericardial effusions can become large and impact the hemodynamics of patients on chronic hemodialysis. Constrictive Pericarditis is also well documented in this population, ultimately resulting in pericardiectomy for definitive treatment. The management of pericardial diseases in ESRD patients involves internists, cardiologists, and nephrologists. Current guidelines lack clarity with respect to the management of pericardial processes in the ESRD population. Our review aims to describe the etiology, classification, clinical manifestations, diagnostic imaging tools, and treatment options of pericardial diseases in this population.

Jorge Betancor - One of the best experts on this subject based on the ideXlab platform.

  • clinical outcomes of pericardial effusions in end stage renal disease Pericarditis associated versus asymptomatic
    Journal of the American College of Cardiology, 2018
    Co-Authors: Karim Abdur Rehman, Jorge Betancor, Bo Xu, Arnav Kumar, Carlos Godoy Rivas, Leslie P Wong, Craig R Asher, Paul Cremer, Allan L Klein
    Abstract:

    Clinical outcomes associated with pericardial effusions related to Uremic Pericarditis (UP) have not been clearly differentiated from asymptomatic effusions in patients with ESRD. Our objectives are: 1) to assess whether pericardial effusions associated with UP are more likely to result in

  • Uremic Pericarditis pericardial effusion and constrictive Pericarditis in end stage renal disease insights and pathophysiology
    Clinical Cardiology, 2017
    Co-Authors: Karim Abdur Rehman, Jorge Betancor, Bo Xu, Arnav Kumar, Carlos Godoy Rivas, Kimi Sato, Leslie P Wong, Craig R Asher, Allan L Klein
    Abstract:

    A rising prevalence of end-stage renal disease (ESRD) has led to a rise in ESRD-related pericardial syndromes, calling for a better understanding of its pathophysiology, diagnoses, and management. Uremic Pericarditis, the most common manifestation of Uremic pericardial disease, is a contemporary problem that calls for intensive hemodialysis, anti-inflammatories, and often, drainage of large inflammatory pericardial effusions. Likewise, asymptomatic pericardial effusions can become large and impact the hemodynamics of patients on chronic hemodialysis. Constrictive Pericarditis is also well documented in this population, ultimately resulting in pericardiectomy for definitive treatment. The management of pericardial diseases in ESRD patients involves internists, cardiologists, and nephrologists. Current guidelines lack clarity with respect to the management of pericardial processes in the ESRD population. Our review aims to describe the etiology, classification, clinical manifestations, diagnostic imaging tools, and treatment options of pericardial diseases in this population.

  • Uremic Pericarditis pericardial effusion and constrictive Pericarditis in end stage renal disease insights and pathophysiology
    Clinical Cardiology, 2017
    Co-Authors: Karim Abdur Rehman, Jorge Betancor, Arnav Kumar, Carlos Godoy Rivas, Kimi Sato, Leslie P Wong, Craig R Asher, Allan L Klein
    Abstract:

    A rising prevalence of end-stage renal disease (ESRD) has led to a rise in ESRD-related pericardial syndromes, calling for a better understanding of its pathophysiology, diagnoses, and management. Uremic Pericarditis, the most common manifestation of Uremic pericardial disease, is a contemporary problem that calls for intensive hemodialysis, anti-inflammatories, and often, drainage of large inflammatory pericardial effusions. Likewise, asymptomatic pericardial effusions can become large and impact the hemodynamics of patients on chronic hemodialysis. Constrictive Pericarditis is also well documented in this population, ultimately resulting in pericardiectomy for definitive treatment. The management of pericardial diseases in ESRD patients involves internists, cardiologists, and nephrologists. Current guidelines lack clarity with respect to the management of pericardial processes in the ESRD population. Our review aims to describe the etiology, classification, clinical manifestations, diagnostic imaging tools, and treatment options of pericardial diseases in this population.

Arnav Kumar - One of the best experts on this subject based on the ideXlab platform.

  • clinical outcomes of pericardial effusions in end stage renal disease Pericarditis associated versus asymptomatic
    Journal of the American College of Cardiology, 2018
    Co-Authors: Karim Abdur Rehman, Jorge Betancor, Bo Xu, Arnav Kumar, Carlos Godoy Rivas, Leslie P Wong, Craig R Asher, Paul Cremer, Allan L Klein
    Abstract:

    Clinical outcomes associated with pericardial effusions related to Uremic Pericarditis (UP) have not been clearly differentiated from asymptomatic effusions in patients with ESRD. Our objectives are: 1) to assess whether pericardial effusions associated with UP are more likely to result in

  • Uremic Pericarditis pericardial effusion and constrictive Pericarditis in end stage renal disease insights and pathophysiology
    Clinical Cardiology, 2017
    Co-Authors: Karim Abdur Rehman, Jorge Betancor, Bo Xu, Arnav Kumar, Carlos Godoy Rivas, Kimi Sato, Leslie P Wong, Craig R Asher, Allan L Klein
    Abstract:

    A rising prevalence of end-stage renal disease (ESRD) has led to a rise in ESRD-related pericardial syndromes, calling for a better understanding of its pathophysiology, diagnoses, and management. Uremic Pericarditis, the most common manifestation of Uremic pericardial disease, is a contemporary problem that calls for intensive hemodialysis, anti-inflammatories, and often, drainage of large inflammatory pericardial effusions. Likewise, asymptomatic pericardial effusions can become large and impact the hemodynamics of patients on chronic hemodialysis. Constrictive Pericarditis is also well documented in this population, ultimately resulting in pericardiectomy for definitive treatment. The management of pericardial diseases in ESRD patients involves internists, cardiologists, and nephrologists. Current guidelines lack clarity with respect to the management of pericardial processes in the ESRD population. Our review aims to describe the etiology, classification, clinical manifestations, diagnostic imaging tools, and treatment options of pericardial diseases in this population.

  • Uremic Pericarditis pericardial effusion and constrictive Pericarditis in end stage renal disease insights and pathophysiology
    Clinical Cardiology, 2017
    Co-Authors: Karim Abdur Rehman, Jorge Betancor, Arnav Kumar, Carlos Godoy Rivas, Kimi Sato, Leslie P Wong, Craig R Asher, Allan L Klein
    Abstract:

    A rising prevalence of end-stage renal disease (ESRD) has led to a rise in ESRD-related pericardial syndromes, calling for a better understanding of its pathophysiology, diagnoses, and management. Uremic Pericarditis, the most common manifestation of Uremic pericardial disease, is a contemporary problem that calls for intensive hemodialysis, anti-inflammatories, and often, drainage of large inflammatory pericardial effusions. Likewise, asymptomatic pericardial effusions can become large and impact the hemodynamics of patients on chronic hemodialysis. Constrictive Pericarditis is also well documented in this population, ultimately resulting in pericardiectomy for definitive treatment. The management of pericardial diseases in ESRD patients involves internists, cardiologists, and nephrologists. Current guidelines lack clarity with respect to the management of pericardial processes in the ESRD population. Our review aims to describe the etiology, classification, clinical manifestations, diagnostic imaging tools, and treatment options of pericardial diseases in this population.